LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2021

May 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2021-04-30

Reporting Person: Swain Judith L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-30	Restricted Stock Units	$0	A	4024	Acquired		Common Stock (4024)	Direct
2021-04-30	Stock Option (Right to Buy)	$5.04	A	6475	Acquired	2031-04-30	Common Stock (6475)	Direct

Footnotes

F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.

F2: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.